ENG
Veterinary Pain Management Market Size, Share, Growth Trends, Industry Analysis, Key Players, Investment Opportunities and Forecast (2025-2032)
Veterinary Pain Management Market Was valued at USD 2.2 Bn. in 2024 and the total revenue is expected to grow at CAGR 6.5 % from 2025 to 2032 Reaching nearly 3.64 Bn. by 2032
Format : PDF | Report ID : SMR_2682
Veterinary Pain Management Market Overview:
Veterinary medicine is the science of treatment, diagnosis, management, and prevention of diseases, disorders, and injuries to non-human animals. Veterinary medicine is Broad or wide range of domestic and wild animals, along with a variety of ailments that affect different species. Market dynamics are driven by an increasing global animal population, increasing number of pet animals kept for companion, high growth of high-end pet service industry, easy avail pills for animal care, improvement in per capita income in developing regions along with rise in amount spent on animal treatment services. According to U.S. Food & Drug Administration statistics, there are around 0.048 billion cases of foodborne disease in the US every year. These diseases arise from pathogens such as Salmonella, Campylobacter, E. coli, Yersinia, and Listeria. Thus, in order to control the prevalence of foodborne diseases, the demand for accurate diagnosis of these diseases increases in animals.
The Veterinary Diagnostics Market is driven by the growing consumables spending on animal healthcare. Hence, there is a significant number of veterinary practitioners who are simultaneously boosting the growth of Veterinary Diagnostics Industry, which is likely to happen in the forecast period. Many common problems in veterinary medicine require diagnostic imaging for diagnosis and management. But imaging is not quite accurate and sometimes does not assist the animal in the way that its species would expect. The Veterinary Diagnostics Market, by Product includes Instruments, Consumables, Kits and Reagents and Software and Services. APPA declared that U.S. spending on pets hit $103.6 billion ($103,600 Billion) in the 2024 edition of its annual state of the industry report, for a 6.7 percent uptick from the prior year.
To get more Insights: Request Free Sample Report
Veterinary Pain Management Market Dynamics:
Redefining Expectations in Veterinary Care to Drive Veterinary Pain Management Market
The relationship between humans and animals has fundamental transformation that has caused ripples in the veterinary industry. The human-animal bond is now stronger than ever with studies showing that 66% of North Americans cherish their pets as family members. This evolution is not only sentimental but also breeds changes in spending patterns, service expectations, and the very nature of veterinary medicine. Increasingly, pet parents are seeking specialized care for their animals, including preventive wellness programs, tough diagnostic measures, and even mental well-being services for their pets. The veterinary trade is thus responding with premium services, extended hours, and personalized care plans based on models drawn from human health care. A case in point is the rise in boutique veterinary facilities, which cater to niche areas such as geriatric pet care, holistic medicine, and sports medicine for active pets. For the industry stakeholders, this brings forth an actionable insight: today, the veterinary arena demands more than mere clinical excellence success hinges on an empathetic understanding of the human-animal bond and the ability to render services that respect and enrich that bonding.
Ex: With modern AI-powered diagnostic tools and telemedicine, pet owners can now consult a vet remotely. Using a smartphone app, they can upload videos of their pet’s symptoms, receive real-time analysis powered by machine learning, and even get prescriptions online.
Pet Adoption Surge to Boost Veterinary Pain Management Market
The significant increase in pet ownership is transforming veterinary service requirements. With 68% of North Americans living with at least one pet as of 2024, veterinary practices are seeing more clients with higher expectations. Today's "pet parents" want animal healthcare that matches human standards. Smart veterinary industry businesses are responding by improving the clinic experience with better digital communication, more convenient hours, and enhanced facilities that resemble human healthcare settings. this pet ownership trend reflects broader social changes: later parenthood, more single-person households, and pets becoming central family members. The 68% pet ownership rate in North America creates opportunities for veterinary services market providers to offer specialized services.
Practices that develop expertise in behavioral medicine, elder pet care, and family-centered preventive services are particularly well-positioned. The most successful veterinary services recognize that pet care now requires both standard medical services and premium "family member" experiences tailored to different client segments.
Limited Research and Development to Restrain the Veterinary Pain Management Market
Although significant progress has been made in animal pain management, further research and development are still necessary. The translation of human pain management advancements to animals is a complex process due to species-specific differences and the limited availability of clinical trials for veterinary-specific drugs. Bridging this gap requires increased investment in research and development, presenting a challenge for market growth.
Lack standardisation of veterinary medicine pain in management and assessment guidelines is a long-standing issue. The subjective experience of pain and differences in animals' responses prevent uniform guidelines. Coordinating pain management procedures between veterinary practices and encouraging uniform procedures is of key importance for the industry.
Veterinary Pain Management Market Segmentation:
Based on Product type the market is segmented into NSAIDs, Opioids, Local Anaesthetics, Alpha-2 Agonist and Others. NSAIDs segment Dominate the market in 2024 and expected to grow during the forecast period. Most prescribed medicines are for osteoarthritis-related pain and inflammation. The NSAIDs establish several advantages over the other relief products, which makes them very popular in the treatment of varied conditions in animals, especially pets. Most alternative reliefs cause some sedation or drowsiness in the animals; these include certain opioids or even some sedative-type medications. The NSAIDs, however, generally do not sedate animals, allowing them to continue their normal activity even though they are feeling some pain. Companies are working toward developing new and improved NSAIDs, with considerably fewer adverse side effects and reactions.
By Animal:
Based on the animal the market is segmented into companion animal and Livestock Animal. The segment Companion animal segment dominate the market in 2024 and expected to grow during the forecast period. While the fundamental change between transformation stands in the aspect of animal ownership, pets are increasingly being treated as family members rather than animals, furthered by the growing acknowledgement among pet owners toward advanced treatments and preventive care on the same level as humans. This trend is particularly so for veterinary practices in urban and rural areas where the veterinary market for higher-end services remains far from saturated. For service providers is to flesh out comprehensive care packages that can address the full lifecycle needs of pets but with a strong emphasis on the emotional connection and clinical outcomes grab a larger share of this rapidly growing market segment.
Based on end use, the hospitals & clinics segment Dominates the market in 2024 and expected to grow during the forecast period. This is due to an increase in the number of patients seeking treatment for various animal ailments at these facilities. Therefore, this sector is expected to increase during the forecast period. Additionally, veterinary clinics and hospitals tend to administer a broad spectrum of treatments and surgeries involving critical pain management, including postoperative care, chronic diseases like arthritis, and cancer pain. With an increasing number of pets undergoing medical interventions in such clinics and hospitals, the demand for good pain management solutions increases.
The other segment which comprises of pharmacies, drug stores, and pet stores. This segment is likely to register at a profitable CAGR through the forecast period. Veterinary pharmacies provide customized pain management prescriptions for pets, such as medicines for arthritis, postoperative recovery, and chronic diseases of pain. Their access to sophisticated pharmaceuticals and capability to dispense prescription and over-the-counter medications makes them crucial for pain management in pets. Pet stores also make a contribution by selling over-the-counter pain management products, including supplements, herbal medicines, and equipment such as orthopedic beds and braces. They also provide easier access to pain relief products, which assist in expanding market reach, especially for mild pain management products.
Veterinary Pain Management Market Regional Analysis:
North America
This region dominated the veterinary pain management market with the largest revenue share of 39.56% in 2024, driven by the region's growing pet population, rising costs for pet care, an increase in the frequency of chronic illnesses, and a surge in orthopedic procedures. In addition, a strong healthcare infrastructure and the existence of significant market players will continue to propel the market in the upcoming years. For example, Vegas Valley Pet Hospital announced in November 2023 that it would be opening a veterinary clinic in Las Vegas. The facility will provide orthopedic and soft tissue pet surgery as part of its specialized care. These factors positively influence market growth.
Veterinary Pain Management Market Competitive Landscape:
The prominent players in the veterinary pain management market are Boehringer Ingelheim International GmbH (Germany), Zoetis Inc. (US), Elanco Animal Health Incorporated (US), Merck & Co., Inc. (US), Dechra Pharmaceuticals (UK), Vetoquinol (France), SeQuent Scientific Limited (India), Norbrook Laboratories Limited (Ireland), Ceva Santé Animale (France), Chanelle Pharma (Ireland), and K-Laser USA (US). New product launches and acquisitions were the major strategies adopted by these payers to maintain their positions in the veterinary pain management market.
|
Veterinary Pain Management Market Scope Table |
|
|
Market Size in 2024 |
USD 2.2 Bn. |
|
Market Size in 2032 |
USD 3.64 Bn. |
|
CAGR (2024-2032) |
6.5% |
|
Historic Data |
2020-2024 |
|
Base Year |
2024 |
|
Forecast Period |
2024-2032 |
|
Segments |
By Product Type NSAIDS Opioids Local Anaesthetics Alpha-2 Agonists Other |
|
By Animal Companion animal Livestock Animal Others |
|
|
By End Use Veterinary hospital Veterinary Clinics Pharmacies and Drug Store |
|
|
By Regional North America Asia Pacific Europe Middle East America South America |
|
|
Regional Scope |
North America- United States, Canada, and Mexico Europe – UK, France, Germany, Italy, Spain, Sweden, Russia, and Rest of Europe Asia Pacific – China, India, Japan, South Korea, Australia, ASEAN, Rest of APAC Middle East and Africa - South Africa, GCC, Egypt, Nigeria, Rest of the Middle East and Africa South America – Brazil, Argentina, Rest of South America |
Key Players in Veterinary Pain Management Market:
North America
- Zoetis Inc. – USA
- Elanco Animal Health – USA
- Merck Animal Health – USA
- Assisi Animal Health – USA
- Covetrus – USA
- K-Laser USA – USA
- Multi Radiance Medical – USA
- Avazzia Inc. – USA
- Sound Technologies – USA
- Banfield Pet Hospital – USA
Europe
11. Boehringer Ingelheim – Germany
12. Dechra Pharmaceuticals – UK
13. Ceva Santé Animale – France
14. Vetoquinol – France
15. Chanelle Pharma – Ireland
16. Norbrook Laboratories – UK
17. Richter Pharma AG – Austria
18. Virbac – France
19. IDEXX Laboratories – USA (major presence in Europe)
20. Bayer Animal Health (now part of Elanco) – Germany
Asia Pacific
21. SeQuent Scientific Ltd. – India
22. Ashish Life Science Pvt. Ltd. – India
23. Century Pharmaceuticals Ltd. – India
24. VETINDIA Pharmaceuticals Ltd. – India
25. Labindia Healthcare Pvt. Ltd. – India
26. Kyoritsu Seiyaku Corporation – Japan
Middle East & Africa
27. MSD Animal Health (Merck) – USA (serves Middle East & Africa)
28. Zomedica Corp. (Assisi Animal Health) – USA (serves Middle East)
South America
29. Ourofino Animal Health – Brazil
30. Eurofarma – Brazil
Frequently Asked Questions
The regenerative medicine or stem cell therapy is used as a treatment for the long term pain management in animals
The large share of veterinary hospitals, can be attributed to the large number of surgical procedures performed in hospitals.
Ethos Veterinary Health LLC, Frolick Dogs LLC, Greencross Vets, IDEXX Laboratories Inc, Kathy Santo Dog Training, Mars, and Incorporated among others.
Veterinary industry accounted the 2.2 billion in 2024 and expected to generate 3.64 billion revenue in 2032
1. Veterinary Pain Management Market Introduction
1.1. Study Assumption and Market Definition
1.2. Scope of the Study
1.3. Executive Summary
2. Veterinary Pain Management Market: Competitive Landscape
2.1. Ecosystem Analysis
2.2. SMR Competition Matrix
2.3. Competitive Landscape
2.4. Key Players Benchmarking
2.4.1. Company Name
2.4.2. Business Segment
2.4.3. End-user Segment
2.4.4. Revenue (2024)
2.4.5. Company Locations
2.5. Market Structure
2.5.1. Market Leaders
2.5.2. Market Followers
2.5.3. Emerging Players
2.6. Mergers and Acquisitions Details
3. Veterinary Pain Management Market: Dynamics
3.1. Veterinary Pain Management Market Trends by Region
3.1.1. North America Veterinary Pain Management Market Trends
3.1.2. Europe Veterinary Pain Management Market Trends
3.1.3. Asia Pacific Veterinary Pain Management Market Trends
3.1.4. Middle East and Africa Veterinary Pain Management Market Trends
3.1.5. South America Veterinary Pain Management Market Trends
3.2. Veterinary Pain Management Market Dynamics
3.2.1. Global Veterinary Pain Management Market Drivers
3.2.2. Global Veterinary Pain Management Market Restraints
3.2.3. Global Veterinary Pain Management Market Opportunities
3.2.4. Global Veterinary Pain Management Market Challenges
3.3. PORTER’s Five Forces Analysis
3.4. PESTLE Analysis
3.5. Trade Analysis
3.6. Regulatory Landscape by Region
3.6.1. North America
3.6.2. Europe
3.6.3. Asia Pacific
3.6.4. Middle East and Africa
3.6.5. South America
3.7. Key Opinion Leader Analysis
4. Veterinary Pain Management Market: Global Market Size and Forecast by Segmentation (by Value in USD Billion) (2024-2032)
4.1. Veterinary Pain Management Market Size and Forecast, By Product (2024-2032)
4.1.1. NSAIDS
4.1.2. Opioids
4.1.3. Local Anaesthetics
4.1.4. Alpha-2 Agonists
4.1.5. Other
4.2. Veterinary Pain Management Market Size and Forecast, By Animal (2024-2032)
4.2.1. Companion animal
4.2.2. Livestock Animal
4.2.3. Others
4.3. Veterinary Pain Management Market Size and Forecast, End Use (2024-2032)
4.3.1. Veterinary hospital
4.3.2. Veterinary Clinics
4.3.3. Pharmacies and Drug Store
4.4. Veterinary Pain Management Market Size and Forecast, by Region (2024-2032)
4.4.1. North America
4.4.2. Europe
4.4.3. Asia Pacific
4.4.4. Middle East and Africa
4.4.5. South America
5. North America Veterinary Pain Management Market Size and Forecast by Segmentation (by Value in USD Billion) (2024-2032)
5.1. North America Veterinary Pain Management Market Size and Forecast, By Product (2024-2032)
5.1.1. NSAIDS
5.1.2. Opioids
5.1.3. Local Anaesthetics
5.1.4. Alpha-2 Agonists
5.1.5. Other
5.2. North America Veterinary Pain Management Market Size and Forecast, By Animal (2024-2032)
5.2.1. Companion animal
5.2.2. Livestock Animal
5.2.3. Others
5.3. North America Veterinary Pain Management Market Size and Forecast, End Use (2024-2032)
5.3.1. Veterinary hospital
5.3.2. Veterinary Clinics
5.3.3. Pharmacies and Drug Store
5.4. North America Veterinary Pain Management Market Size and Forecast, by Country (2024-2032)
5.4.1. United States
5.4.1.1. United States Veterinary Pain Management Market Size and Forecast, By Product (2024-2032)
5.4.1.1.1. NSAIDS
5.4.1.1.2. Opioids
5.4.1.1.3. Local Anaesthetics
5.4.1.1.4. Alpha-2 Agonists
5.4.1.1.5. Other
5.4.1.2. United States Veterinary Pain Management Market Size and Forecast, By Animal (2024-2032)
5.4.1.2.1. Companion animal
5.4.1.2.2. Livestock Animal
5.4.1.2.3. Others
5.4.1.3. United States Veterinary Pain Management Market Size and Forecast, End Use (2024-2032)
5.4.1.3.1. Veterinary hospital
5.4.1.3.2. Veterinary Clinics
5.4.1.3.3. Pharmacies and Drug Store
5.4.1.4. Canada Veterinary Pain Management Market Size and Forecast, By Product (2024-2032)
5.4.1.4.1. NSAIDS
5.4.1.4.2. Opioids
5.4.1.4.3. Local Anaesthetics
5.4.1.4.4. Alpha-2 Agonists
5.4.1.4.5. Other
5.4.1.5. Canada Veterinary Pain Management Market Size and Forecast, By Animal (2024-2032)
5.4.1.5.1. Companion animal
5.4.1.5.2. Livestock Animal
5.4.1.5.3. Others
5.4.2. Canada Veterinary Pain Management Market Size and Forecast, End Use (2024-2032)
5.4.2.1.1. Veterinary hospital
5.4.2.1.2. Veterinary Clinics
5.4.2.1.3. Pharmacies and Drug Store
5.4.3. Mexico
5.4.3.1. Mexico Veterinary Pain Management Market Size and Forecast, By Product (2024-2032)
5.4.3.1.1. NSAIDS
5.4.3.1.2. Opioids
5.4.3.1.3. Local Anaesthetics
5.4.3.1.4. Alpha-2 Agonists
5.4.3.1.5. Other
5.4.3.2. Mexico Veterinary Pain Management Market Size and Forecast, By Animal (2024-2032)
5.4.3.2.1. Companion animal
5.4.3.2.2. Livestock Animal
5.4.3.2.3. Others Others
5.4.3.3. Mexico Veterinary Pain Management Market Size and Forecast, End Use (2024-2032)
5.4.3.3.1. Veterinary hospital
5.4.3.3.2. Veterinary Clinics
5.4.3.3.3. Pharmacies and Drug Store
6. Europe Veterinary Pain Management Market Size and Forecast by Segmentation (by Value in USD Billion) (2024-2032)
6.1. Europe Veterinary Pain Management Market Size and Forecast, By Product (2024-2032)
6.2. Europe Veterinary Pain Management Market Size and Forecast, By Animal (2024-2032)
6.3. Europe Veterinary Pain Management Market Size and Forecast, End Use (2024-2032)
6.4. Europe Veterinary Pain Management Market Size and Forecast, by Country (2024-2032)
6.4.1. United Kingdom
6.4.1.1. United Kingdom Veterinary Pain Management Market Size and Forecast, By Product (2024-2032)
6.4.1.2. United Kingdom Veterinary Pain Management Market Size and Forecast, By Animal (2024-2032)
6.4.1.3. United Kingdom Veterinary Pain Management Market Size and Forecast, End Use (2024-2032)
6.4.2. France
6.4.2.1. France Veterinary Pain Management Market Size and Forecast, By Product (2024-2032)
6.4.2.2. France Veterinary Pain Management Market Size and Forecast, By Animal (2024-2032)
6.4.2.3. France Veterinary Pain Management Market Size and Forecast, End Use (2024-2032)
6.4.3. Germany
6.4.3.1. Germany Veterinary Pain Management Market Size and Forecast, By Product (2024-2032)
6.4.3.2. Germany Veterinary Pain Management Market Size and Forecast, By Animal (2024-2032)
6.4.3.3. Germany Veterinary Pain Management Market Size and Forecast, End Use (2024-2032)
6.4.4. Italy
6.4.4.1. Italy Veterinary Pain Management Market Size and Forecast, By Product (2024-2032)
6.4.4.2. Italy Veterinary Pain Management Market Size and Forecast, By Animal (2024-2032)
6.4.4.3. Italy Veterinary Pain Management Market Size and Forecast, End Use (2024-2032)
6.4.5. Spain
6.4.5.1. Spain Veterinary Pain Management Market Size and Forecast, By Product (2024-2032)
6.4.5.2. Spain Veterinary Pain Management Market Size and Forecast, By Animal (2024-2032)
6.4.5.3. Spain Veterinary Pain Management Market Size and Forecast, End Use (2024-2032)
6.4.6. Sweden
6.4.6.1. Sweden Veterinary Pain Management Market Size and Forecast, By Product (2024-2032)
6.4.6.2. Sweden Veterinary Pain Management Market Size and Forecast, By Animal (2024-2032)
6.4.6.3. Sweden Veterinary Pain Management Market Size and Forecast, End Use (2024-2032)
6.4.7. Austria
6.4.7.1. Austria Veterinary Pain Management Market Size and Forecast, By Product (2024-2032)
6.4.7.2. Austria Veterinary Pain Management Market Size and Forecast, By Animal (2024-2032)
6.4.7.3. Austria Veterinary Pain Management Market Size and Forecast, End Use (2024-2032)
6.4.8. Rest of Europe
6.4.8.1. Rest of Europe Veterinary Pain Management Market Size and Forecast, By Product (2024-2032)
6.4.8.2. Rest of Europe Veterinary Pain Management Market Size and Forecast, By Animal (2024-2032)
6.4.8.3. Rest of Europe Veterinary Pain Management Market Size and Forecast, End Use (2024-2032)
7. Asia Pacific Veterinary Pain Management Market Size and Forecast by Segmentation (by Value in USD Billion) (2024-2032)
7.1. Asia Pacific Veterinary Pain Management Market Size and Forecast, By Product (2024-2032)
7.2. Asia Pacific Veterinary Pain Management Market Size and Forecast, By Animal (2024-2032)
7.3. Asia Pacific Veterinary Pain Management Market Size and Forecast, End Use (2024-2032)
7.4. Asia Pacific Veterinary Pain Management Market Size and Forecast, by Country (2024-2032)
7.4.1. China
7.4.1.1. China Veterinary Pain Management Market Size and Forecast, By Product (2024-2032)
7.4.1.2. China Veterinary Pain Management Market Size and Forecast, By Animal (2024-2032)
7.4.1.3. China Veterinary Pain Management Market Size and Forecast, End Use (2024-2032)
7.4.2. S Korea
7.4.2.1. S Korea Veterinary Pain Management Market Size and Forecast, By Product (2024-2032)
7.4.2.2. S Korea Veterinary Pain Management Market Size and Forecast, By Animal (2024-2032)
7.4.2.3. S Korea Veterinary Pain Management Market Size and Forecast, End Use (2024-2032)
7.4.3. Japan
7.4.3.1. Japan Veterinary Pain Management Market Size and Forecast, By Product (2024-2032)
7.4.3.2. Japan Veterinary Pain Management Market Size and Forecast, By Animal (2024-2032)
7.4.3.3. Japan Veterinary Pain Management Market Size and Forecast, End Use (2024-2032)
7.4.4. India
7.4.4.1. India Veterinary Pain Management Market Size and Forecast, By Product (2024-2032)
7.4.4.2. India Veterinary Pain Management Market Size and Forecast, By Animal (2024-2032)
7.4.4.3. India Veterinary Pain Management Market Size and Forecast, End Use (2024-2032)
7.4.5. Australia
7.4.5.1. Australia Veterinary Pain Management Market Size and Forecast, By Product (2024-2032)
7.4.5.2. Australia Veterinary Pain Management Market Size and Forecast, By Animal (2024-2032)
7.4.5.3. Australia Veterinary Pain Management Market Size and Forecast, End Use (2024-2032)
7.4.6. Indonesia
7.4.6.1. Indonesia Veterinary Pain Management Market Size and Forecast, By Product (2024-2032)
7.4.6.2. Indonesia Veterinary Pain Management Market Size and Forecast, By Animal (2024-2032)
7.4.6.3. Indonesia Veterinary Pain Management Market Size and Forecast, End Use (2024-2032)
7.4.7. Malaysia
7.4.7.1. Malaysia Veterinary Pain Management Market Size and Forecast, By Product (2024-2032)
7.4.7.2. Malaysia Veterinary Pain Management Market Size and Forecast, By Animal (2024-2032)
7.4.7.3. Malaysia Veterinary Pain Management Market Size and Forecast, End Use (2024-2032)
7.4.8. Vietnam
7.4.8.1. Vietnam Veterinary Pain Management Market Size and Forecast, By Product (2024-2032)
7.4.8.2. Vietnam Veterinary Pain Management Market Size and Forecast, By Animal (2024-2032)
7.4.8.3. Vietnam Veterinary Pain Management Market Size and Forecast, End Use (2024-2032)
7.4.9. Taiwan
7.4.9.1. Taiwan Veterinary Pain Management Market Size and Forecast, By Product (2024-2032)
7.4.9.2. Taiwan Veterinary Pain Management Market Size and Forecast, By Animal (2024-2032)
7.4.9.3. Taiwan Veterinary Pain Management Market Size and Forecast, End Use (2024-2032)
7.4.10. Rest of Asia Pacific
7.4.10.1. Rest of Asia Pacific Veterinary Pain Management Market Size and Forecast, By Product (2024-2032)
7.4.10.2. Rest of Asia Pacific Veterinary Pain Management Market Size and Forecast, By Animal (2024-2032)
7.4.10.3. Rest of Asia Pacific Veterinary Pain Management Market Size and Forecast, End Use (2024-2032)
8. Middle East and Africa Veterinary Pain Management Market Size and Forecast by Segmentation (by Value in USD Billion) (2024-2032)
8.1. Middle East and Africa Veterinary Pain Management Market Size and Forecast, By Product (2024-2032)
8.2. Middle East and Africa Veterinary Pain Management Market Size and Forecast, By Animal (2024-2032)
8.3. Middle East and Africa Veterinary Pain Management Market Size and Forecast, End Use (2024-2032)
8.4. Middle East and Africa Veterinary Pain Management Market Size and Forecast, by Country (2024-2032)
8.4.1. South Africa
8.4.1.1. South Africa Veterinary Pain Management Market Size and Forecast, By Product (2024-2032)
8.4.1.2. South Africa Veterinary Pain Management Market Size and Forecast, By Animal (2024-2032)
8.4.1.3. South Africa Veterinary Pain Management Market Size and Forecast, End Use (2024-2032)
8.4.2. GCC
8.4.2.1. GCC Veterinary Pain Management Market Size and Forecast, By Product (2024-2032)
8.4.2.2. GCC Veterinary Pain Management Market Size and Forecast, By Animal (2024-2032)
8.4.2.3. GCC Veterinary Pain Management Market Size and Forecast, End Use (2024-2032)
8.4.3. Nigeria
8.4.3.1. Nigeria Veterinary Pain Management Market Size and Forecast, By Product (2024-2032)
8.4.3.2. Nigeria Veterinary Pain Management Market Size and Forecast, By Animal (2024-2032)
8.4.3.3. Nigeria Veterinary Pain Management Market Size and Forecast, End Use (2024-2032)
8.4.4. Rest of ME&A
8.4.4.1. Rest of ME&A Veterinary Pain Management Market Size and Forecast, By Product (2024-2032)
8.4.4.2. Rest of ME&A Veterinary Pain Management Market Size and Forecast, By Animal (2024-2032)
8.4.4.3. Rest of ME&A Veterinary Pain Management Market Size and Forecast, End Use (2024-2032)
9. South America Veterinary Pain Management Market Size and Forecast by Segmentation (by Value in USD Billion) (2024-2032)
9.1. South America Veterinary Pain Management Market Size and Forecast, By Product (2024-2032)
9.2. South America Veterinary Pain Management Market Size and Forecast, By Animal (2024-2032)
9.3. South America Veterinary Pain Management Market Size and Forecast, End Use (2024-2032)
9.4. South America Veterinary Pain Management Market Size and Forecast, by Country (2024-2032)
9.4.1. Brazil
9.4.1.1. Brazil Veterinary Pain Management Market Size and Forecast, By Product (2024-2032)
9.4.1.2. Brazil Veterinary Pain Management Market Size and Forecast, By Animal (2024-2032)
9.4.1.3. Brazil Veterinary Pain Management Market Size and Forecast, End Use (2024-2032)
9.4.2. Argentina
9.4.2.1. Argentina Veterinary Pain Management Market Size and Forecast, By Product (2024-2032)
9.4.2.2. Argentina Veterinary Pain Management Market Size and Forecast, By Animal (2024-2032)
9.4.2.3. Argentina Veterinary Pain Management Market Size and Forecast, End Use (2024-2032)
9.4.3. Rest of South America
9.4.3.1. Rest of South America Veterinary Pain Management Market Size and Forecast, By Product (2024-2032)
9.4.3.2. Rest of South America Veterinary Pain Management Market Size and Forecast, By Animal (2024-2032)
9.4.3.3. Rest of South America Veterinary Pain Management Market Size and Forecast, End Use (2024-2032)
10. Company Profile: Key Players
10.1. Zoetis Inc. – USA
10.1.1. Company Overview
10.1.2. Business Portfolio
10.1.3. Financial Overview
10.1.4. SWOT Analysis
10.1.5. Strategic Analysis
10.1.6. Recent Developments
10.2. Elanco Animal Health – USA
10.3. Merck Animal Health – USA
10.4. Assisi Animal Health – USA
10.5. Covetrus – USA
10.6. K-Laser USA – USA
10.7. Multi Radiance Medical – USA
10.8. Avazzia Inc. – USA
10.9. Sound Technologies – USA
10.10. Banfield Pet Hospital – USA
10.11. Boehringer Ingelheim – Germany
10.12. Dechra Pharmaceuticals – UK
10.13. Ceva Santé Animale – France
10.14. Vetoquinol – France
10.15. Chanelle Pharma – Ireland
10.16. Norbrook Laboratories – UK
10.17. Richter Pharma AG – Austria
10.18. Virbac – France
10.19. IDEXX Laboratories – USA (major presence in Europe)
10.20. Bayer Animal Health (now part of Elanco) – Germany
10.21. SeQuent Scientific Ltd. – India
10.22. Ashish Life Science Pvt. Ltd. – India
10.23. Century Pharmaceuticals Ltd. – India
10.24. VETINDIA Pharmaceuticals Ltd. – India
10.25. Labindia Healthcare Pvt. Ltd. – India
10.26. Kyoritsu Seiyaku Corporation – Japan
10.27. MSD Animal Health (Merck) – USA (serves Middle East & Africa)
10.28. Zomedica Corp. (Assisi Animal Health) – USA (serves Middle East)
10.29. Ourofino Animal Health – Brazil
10.30. Eurofarma – Brazil
11. Key Findings
12. Analyst Recommendations
13. Veterinary pain management: Research Methodology
